Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454713 · ClinicalTrials.gov registry record
Retrospective Analysis of Veritas in Breast Reconstruction
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 54
- Enrollment target
NCT01454713: Completed study, sponsored by Baxter Healthcare Corporation.
NCT01454713 is a clinical trial that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01454713 has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
Retrospective data collection of the use of Veritas in breast reconstruction surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-10 |
What the finished NCT01454713 record still lists
NCT01454713 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01454713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01454713 about?
NCT01454713 is a clinical study titled "Retrospective Analysis of Veritas in Breast Reconstruction". Retrospective data collection of the use of Veritas in breast reconstruction surgery
What is the current status of trial NCT01454713?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2010-10. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01454713?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia